Cytosorbents (CTSO) Other Non Operating Income (2015 - 2026)

Cytosorbents (CTSO) has reported Other Non Operating Income for 12 consecutive years, with -$911000.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Other Non Operating Income fell 114.75% year-over-year to -$911000.0; the trailing twelve-month figure through Jun 2026 stood at -$2.0 million (down 128.98% YoY), and the FY2025 full-year result was $9.3 million, up 320.62% from the prior year.
• Other Non Operating Income grew to -$911000.0 in Q2 2026 per CTSO's latest filing, from -$1.2 million in the prior quarter.
• Across five years, Other Non Operating Income topped out at $6.2 million in Q2 2025 and bottomed at -$4.9 million in Q4 2024.
• Historically, Other Non Operating Income has averaged $136554.8 across 5 years, with a median of -$304000.0 in 2024.
• The sharpest annual moves came in 2022 and 2025: Other Non Operating Income plunged 1177.6% in 2022, then jumped 1235.66% in 2025.
• Over 5 years, Other Non Operating Income stood at $4.5 million in 2022, then plunged by 40.61% to $2.7 million in 2023, then plunged by 282.8% to -$4.9 million in 2024, then surged by 103.93% to $193000.0 in 2025, then slumped by 572.02% to -$911000.0 in 2026.
• According to Business Quant data, Other Non Operating Income over the past three periods registered -$911000.0, -$1.2 million, and $193000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.